|
Section 4 Screening for Diabetic Retinopathy |
4.1
Methodology and Validation
The Diabetic Retinopathy Study Group26 and the British and Study Group 27 have shown that photocoagulation is effective in the treatment of proliferative retinopathy. Treatment is particularly effective when given early and adequately and joint initiatives for screening for diabetic retinopathy as shown by the Brunel study1. . Similarly the British and Study28 and the Early Treatment of Diabetic Retinopathy Study14 have shown that visual loss due to diabetic maculopathy can be reduced, especially when the lesion are early, and the vision still good. . As the earliest forms of retinopathy, when treatment is also most effective, are not associated with visual symptoms, it is essential that these should be detected. DR therefore represents an excellent paradigm for screening as laid out in the principles for screening of human disease29. Screening for diabetic retinopathy is cost effective in health economic terms30-32. . Comprehensive screening programmes for DR in the UK are difficult to put in place since there is as yet no complete register of all diabetics in all health regions. however, attempts should be made to achieve full coverage of the patient population through the establishment of district wide diabetes registers. . Screening may be undertaken for two reasons: the detection of disease of any severity and the detection of disease of sufficient severity to require consideration for treatment. The latter constitutes the "indications for referral to the ophthalmologist" and is dealt with below. . Screening modalities include fundoscopy, which can be performed by various individuals with different levels of expertise, and photography with a fundus camera with or without mydriasis. . Several studies on the value of screening11,30,32-39 have led to the following general recommendations proposed in a parallel guidelines document in preparation by the European Consensus Document and the conference of Scottish Royal Colleges: .
should be screened . include a measurement of visual acuity and examination of the fundus through a dilated pupil . and comprehensive manner and will involve a combination of: . a. diabetologists for patients attending hospital diabetic clinics . b. optometrists, usually in densely populated urban areas, as primary screeners for diabetic patients being treated by their general practitioner, if the GP does not wish to perform the screening him/herself . c. photographic screening for patients for whom neither of the above is available eg. in rural communities. Photographs would be evaluated by primary screeners at diabetic clinics or GP practices. . Combined modality screening may be useful in certain circumstances. In this case the opinion of a trained ophthalmoscopist, whether physician, ophthalmologist or optometrist, is combined with photography through a dilated pupil, the photographs being evaluated by a trained observer. While labour intensive, the number of missed is greatly reduced. Whichever screening method is employed in any region, it is important that the results of screening and indeed treatment outcomes from the screening programme, are audited and validated. . With rapid advancement of technology, new methods for screening are now available including digital photographic and computerized methods for detection and assessment of retinopathy. While opinions remain divided as to the best screening modalities, it should dbe possible to develop an effective screening programme based on a single modality, thereby reducing duplication, cost and sources of error. A number of research programmes are currently in progress to evaluate the various modalities. All new screening methods however, should be tested for sensitivity and specificity against known standards. In addition, the screening procedure in each centre should be audited regularly by independent assessors to ensure uniform standards of care. . 4.2 Indications for referral to an ophthalmologist The main purpose of screening is to detect patients who require treatment and to refer them to the ophthalmologist in good time, when vision can be saved, or possibly improved. . Urgent referral is indicated in the following conditions:
. These patients should be seen on the same day in the case of retinal detachment and vitreous haemorrhage and within 2-3 days in the case of new vessels. . Early referral is indicated in the following conditions:
the centre of the fovea These patients should be seen within 3-4 weeks. .Routine referral for an ophthalmological opinion should be made for the following conditions:
within the major temporal arcade but not threatening the macula to determine cause of visual loss. |
|
. |